Information Provided By: 
Fly News Breaks for April 13, 2015
TKPYY, AZN
Apr 13, 2015 | 08:54 EDT
SunTrust says that FDA briefing documents say that AstraZeneca's (AZN) Onglyza showed a heart failure signal in the SAVOR outcome trial, while Takeda's (TKPYY) Nesina showed no difference versus placebo in another study.
News For AZN;TKPYY From the Last 2 Days
AZN
Apr 23, 2024 | 11:16 EDT
Bearish flow noted in AstraZeneca with 3,362 puts trading, or 1.7x expected. Most active are 4/26 weekly 70 puts and May-24 70 calls, with total volume in those strikes near 3,600 contracts. The Put/Call Ratio is 1.72, while ATM IV is up nearly 2 points on the day. Earnings are expected on April 25th.
